Methionine (CID 876) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(1)
 
 
Inactive(134)
 
 
Inconclusive(15)
 
 
Unspecified(1)
 
 
Top Targets:
Tubulin-bindi..(2)
 
 
NR LBD TR(2)
 
 
DUF3652(2)
 
 
RIP(2)
 
 
Firefly Luc l..(2)
 
 
BioAssay Types:
Literature(62)
 
 
 
 
Confirmatory(56)
 
 
 
Screening(6)
 
 
 
BioActivity Types:
Potency(54)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 81    Data Row: 151   Total Pages: 4   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID14720399]
 Compound Screen Assay, Human MAT2A [AID508, Type: screening]methionine adenosyltransferase II, alpha [Homo sapiens] [gi:5174529]
View
2
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View
3
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_1, Type: Literature]
View
4
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_13, Type: Literature]
View
5
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_60, Type: Literature]
View
6
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_61, Type: Literature]
View
7
[SID29215370]
Potency Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
8
[SID29215370]
Potency Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
9
[SID29215370]
Potency Quantitative High-Throughput Screen for Regulators of Epigenetic Control [AID1865, Type: confirmatory]
View
10
[SID29215370]
Potency qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory]
View
11
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_51, Type: Literature]
View
12
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_52, Type: Literature]
View
13
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_53, Type: Literature]
View
14
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_54, Type: Literature]
View
15
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_55, Type: Literature]
View
16
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_56, Type: Literature]
View
17
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_57, Type: Literature]
View
18
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_58, Type: Literature]
View
19
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_34, Type: Literature]
View
20
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_35, Type: Literature]
View
21
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_36, Type: Literature]
View
22
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_37, Type: Literature]
View
23
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_38, Type: Literature]
View
24
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_40, Type: Literature]
View
25
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_41, Type: Literature]
View
26
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_42, Type: Literature]
View
27
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_43, Type: Literature]
View
28
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_44, Type: Literature]
View
29
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_21, Type: Literature]
View
30
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_22, Type: Literature]
View
31
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_46, Type: Literature]
View
32
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_47, Type: Literature]
View
33
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_48, Type: Literature]
View
34
[SID29215370]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_49, Type: Literature]
View
35
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other]
View
36
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other]
View
37
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other]
View
38
[SID74759]
 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other]
View
39
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other]
View
40
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other]
View
41
[SID74759]
 NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other]
View
42
[SID84953]
 NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other]
View
43
[SID84953]
 NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other]
View
44
[SID84953]
 NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other]
View
45
[SID84953]
 NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice [AID192, Type: other]
View
46
[SID84953]
 NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice [AID194, Type: other]
View
47
[SID84953]
 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other]
View
48
[SID84953]
 NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice [AID274, Type: other]
View
49
[SID84953]
 NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other]
View
50
[SID84953]
 NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other]
View